News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
557,135 Results
Type
Article (40394)
Company Profile (75)
Press Release (516666)
Multimedia
Podcasts (44)
Webinars (11)
Section
Business (155233)
Career Advice (2433)
Deals (28260)
Drug Delivery (98)
Drug Development (73217)
Employer Resources (141)
FDA (14287)
Job Trends (12366)
News (276373)
Policy (27379)
Tag
Academia (2559)
Academic (1)
Accelerated approval (5)
Adcomms (26)
Allergies (78)
Alliances (39050)
ALS (90)
Alzheimer's disease (1391)
Antibody-drug conjugate (ADC) (127)
Approvals (14276)
Artificial intelligence (239)
Autoimmune disease (22)
Automation (16)
Bankruptcy (314)
Best Places to Work (10110)
BIOSECURE Act (15)
Biosimilars (90)
Biotechnology (60)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (268)
Cancer (2150)
Cardiovascular disease (185)
Career advice (2045)
Career pathing (32)
CAR-T (143)
Cell therapy (394)
Cervical cancer (16)
Clinical research (59773)
Collaboration (710)
Company closure (1)
Compensation (278)
Complete response letters (22)
COVID-19 (2465)
CRISPR (39)
C-suite (251)
Cystic fibrosis (84)
Data (2127)
Decentralized trials (2)
Denatured (6)
Depression (51)
Diabetes (255)
Diagnostics (5734)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (38)
Drug discovery (111)
Drug pricing (93)
Drug shortages (23)
Duchenne muscular dystrophy (89)
Earnings (56682)
Editorial (38)
Employer branding (18)
Employer resources (128)
Events (77000)
Executive appointments (719)
FDA (15462)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (664)
Gene editing (98)
Generative AI (19)
Gene therapy (301)
GLP-1 (693)
Government (4144)
Grass and pollen (5)
Guidances (64)
Healthcare (16581)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (126)
Indications (27)
Infectious disease (2607)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (88)
Interviews (522)
IPO (12763)
IRA (41)
Job creations (2635)
Job search strategy (1674)
Kidney cancer (11)
Labor market (19)
Layoffs (422)
Leadership (23)
Legal (5862)
Liver cancer (73)
Lung cancer (319)
Lymphoma (144)
Machine learning (6)
Management (51)
Manufacturing (253)
MASH (74)
Medical device (11596)
Medtech (11600)
Mergers & acquisitions (15980)
Metabolic disorders (665)
Multiple sclerosis (78)
NASH (23)
Neurodegenerative disease (99)
Neuropsychiatric disorders (31)
Neuroscience (1937)
NextGen: Class of 2025 (5669)
Non-profit (4025)
Now hiring (31)
Obesity (344)
Opinion (210)
Ovarian cancer (72)
Pain (91)
Pancreatic cancer (82)
Parkinson's disease (145)
Partnered (17)
Patents (218)
Patient recruitment (106)
Peanut (41)
People (51419)
Pharmaceutical (22)
Pharmacy benefit managers (10)
Phase I (18380)
Phase II (26291)
Phase III (20063)
Pipeline (1162)
Policy (132)
Postmarket research (2328)
Preclinical (7527)
Press Release (54)
Prostate cancer (99)
Psychedelics (37)
Radiopharmaceuticals (214)
Rare diseases (362)
Real estate (4204)
Recruiting (56)
Regulatory (19381)
Reports (25)
Research institute (2136)
Resumes & cover letters (356)
Rett syndrome (5)
RNA editing (3)
RSV (39)
Schizophrenia (75)
Series A (117)
Series B (74)
Service/supplier (4)
Sickle cell disease (53)
Special edition (10)
Spinal muscular atrophy (145)
Sponsored (28)
Startups (2800)
State (2)
Stomach cancer (14)
Supply chain (57)
Tariffs (31)
The Weekly (37)
Vaccines (639)
Venture capitalists (31)
Weight loss (232)
Women's health (25)
Worklife (17)
Date
Last 7 days (770)
Last 30 days (2158)
Last 365 days (28693)
2025 (9432)
2024 (31006)
2023 (34728)
2022 (45219)
2021 (48500)
2020 (47058)
2019 (40419)
2018 (30648)
2017 (27574)
2016 (26257)
2015 (30766)
2014 (23153)
2013 (18925)
2012 (20250)
2011 (21102)
2010 (18731)
Location
Africa (724)
Alabama (48)
Alaska (5)
Arizona (148)
Arkansas (11)
Asia (34188)
Australia (7061)
California (5094)
Canada (1821)
China (469)
Colorado (228)
Connecticut (216)
Delaware (133)
Europe (76170)
Florida (820)
Georgia (182)
Idaho (50)
Illinois (487)
India (23)
Indiana (273)
Iowa (7)
Japan (151)
Kansas (90)
Kentucky (19)
Louisiana (8)
Maine (49)
Maryland (784)
Massachusetts (3646)
Michigan (195)
Minnesota (304)
Mississippi (1)
Missouri (75)
Montana (25)
Nebraska (22)
Nevada (56)
New Hampshire (66)
New Jersey (1526)
New Mexico (21)
New York (1506)
North Carolina (809)
North Dakota (5)
Northern California (2222)
Ohio (173)
Oklahoma (7)
Oregon (29)
Pennsylvania (1159)
Puerto Rico (12)
Rhode Island (27)
South America (997)
South Carolina (19)
South Dakota (1)
Southern California (1967)
Tennessee (84)
Texas (779)
United States (19438)
Utah (166)
Virginia (138)
Washington D.C. (50)
Washington State (472)
West Virginia (3)
Wisconsin (43)
557,135 Results for "microline surgical formerly known as microline pentax".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Microline Surgical Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Retraction Limited
Microline Surgical, Inc., a subsidiary of HOYA Corporation, announced that it has acquired the rights to certain laparoscopic instrumentation assets from RETRACTION Limited.
November 22, 2023
·
3 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
PENTAX Medical obtained US FDA 510(k) clearance for new models of the PENTAX Medical i20c Video Endoscope Series
December 10, 2024
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
New Models of PENTAX Medical i20c Video Endoscope Series Obtain CE Marks
PENTAX Medical, a division of HOYA Group, have obtained CE marks for new models of PENTAX Medical i20c Video Endoscope Series - PENTAX Medical Video Colonoscope EC34-i20c, PENTAX Medical Video Upper GI Scope EG27-i20c and R/L Knob Adaptor OE-B17.
February 27, 2024
·
3 min read
Drug Development
Eyenovia Announces Positive Results from VISION-2 Phase 3 Study of MicroLine as a Potential On-Demand Treatment for Presbyopia
Eyenovia, Inc. (NASDAQ: EYEN) today announced positive results from its VISION-2 Phase 3 study of MicroLine as a potential topical, on-demand treatment for presbyopia.
October 20, 2022
·
8 min read
Pharm Country
PENTAX Medical launches 4K video processor, PENTAX Medical INSPIRA™(EPK-i8020c) and the ergonomic i20c endoscopes in United States
PENTAX Medical America Inc., a division of HOYA Group, has launched two of its latest innovations: the PENTAX Medical INSPIRA™, a premier 4K video processor, and the i20c video endoscope series.
October 25, 2023
·
4 min read
Press Releases
Celltrion’s Remdantry™, previously known as Inflectra®, will be available in Canada as of April 1, 2025
March 27, 2025
·
3 min read
Press Releases
LEM Surgical Announces FDA Clearance of Dynamis Robotic Surgical System
April 24, 2025
·
2 min read
Press Releases
Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio
April 22, 2025
·
8 min read
1 of 55,714
Next
